Table 1.

Brady-PEA vs non-Brady PEA arrests. Items in bold have P-value <0.05.

	Non-brady PEA (n = 110)	Brady-PEA (n = 66)	P-value
Age (mean ± SD)	61.7 ± 14.6	58.8 ± 15.1	0.21
Female Sex	35 (31.8%)	18 (27.3%)	0.61
Coronary Artery Disease	31 (28.8%)	21 (31.8%)	0.61
Cardiac implantable electronic device	16 (14.5%)	2 (3.0%)	0.02
Obesity	31 (28.4%)	19 (28.8%)	1.0
Monitored Unit (n = 146)	96 (87.3%)	34 (94.4%)	0.36
Witnessed	96 (87.3%)	60 (90.1%)	0.63
Heart Failure	29 (26.4%)	18 (27.3%)	1.0
Beta Blocker	25 (22.7%)	21 (31.8%)	0.22
Calcium Channel Blocker	7 (6.4%)	3 (4.5%)	0.75
Antiarrhythmic Drug	16 (14.5%)	13 (19.7%)	0.41
Renal Disease	21 (19.1%)	11 (16.7%)	0.84
Lung Disease	32 (29.1%)	24 (36.4%)	0.32
Cause			0.006
Acidemia	5 (4.5%)	1 (1.5%)
Cardiac tamponade	4 (3.6%)	3 (4.5%)
Electrolyte ab normality	3 (2.7%)	3 (4.5%)
Respiratory	30 (27.3%)	24 (36.4)
Myocardial infarction	4 (3.6%)	7 (10.6%)
Pulmonary embolus	5 (4.5%)	4 (6.1%)
Shock	36 (32.7%)	8 (12.1%)
Other	10 (9.1%)	11 (16.7%)
Unknown	13 (11.8%)	2 (3.0%)
Respiratory arrest	30 (27.3%)	24 (36.4%)	0.24
Intubated prior to code	38 (34.5%)	15 (22.7%)	0.12